监管毒理学的双重转型:向化学品2.0迈进,并逐步淘汰动物试验
Andrew P Worth1, Elisabet Berggren1
1European Commission, Joint Research Centre (JRC), Ispra, Italy.
概括
欧洲联盟 欧洲联盟
科学领域:
- 化学安全评估 化学安全评估
- 监管科学是一种监管科学.
- 毒理学 毒理学 毒理学
背景情况:
- 欧洲的化学品监管面临着提高有效性和效率的要求.
- 在化学品安全评估中,有政治动力逐步取消动物试验.
- 当前的监管实践可能涉及冗余的测试和缺乏协调.
研究的目的:
- 建议逐步淘汰动物试验可以与提高监管效率和效率保持一致.
- 引入基于生物推理的化学安全评估框架.
- 倡导向可持续的监管生态系统过渡.
主要方法:
- 提出一个以生物推理为中心的框架,以及对测试的分层方法.
- 强调逐步采用非动物方法.
- 倡导开发综合测试策略和评估方法.
主要成果:
- 逐步淘汰动物试验的路线图可以作为通往更高效和有效的监管体系的途径.
- 一个分层,有生物学理由的框架支持比例性和成本效益.
- 专注于方法结果和保护水平,而不是动物试验预测,提高了评估.
结论:
- 有效,高效和无动物化学品监管的需求是相容的.
- 使用非动物方法的生物理性,分层方法提供了可持续的监管未来.
- 将重点转移到生物结果将改善化学品安全评估.
相关概念视频
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Effects of Chemicals: Overview
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Toxicokinetics: Overview
Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...


